No Data
Tianjin Da Ren Tang Wins Approval for Loxoprofen Sodium Patch in Fast-Growing Market
Darentang: Equity stake held by indirect controlling shareholder in investee company listed for transfer
Gelonghui, September 24 — Darentang announced that Shanghai Liuluguang, a 35%-holding shareholder of its indirect controlling shareholder, Jinshenhui Pharmaceutical, is undergoing a public transfer
Tianjin Pharmaceutical Da Ren Tang Expands Business Scope and Updates Articles of Association
Tianjin Da Ren Tang Wins Shareholder Backing for New Pay Policy and 2026 Director Remuneration
Tianjin Da Ren Tang Schedules Online Briefing on HY2026 Financial Results
Tianjin Da Ren Tang Board Clears FY2026 Half-Year Reports and Governance Changes